Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001571049-16-013830
Filing Date
2016-04-12
Accepted
2016-04-12 16:07:06
Documents
6
Effectiveness Date
2016-04-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS t1600915_def14a.htm DEFA14A 19438
2 GRAPHIC pg01.jpg GRAPHIC 570959
3 GRAPHIC pg02.jpg GRAPHIC 883485
4 GRAPHIC pg03.jpg GRAPHIC 542860
5 GRAPHIC pg04.jpg GRAPHIC 400867
6 GRAPHIC pg05.jpg GRAPHIC 246561
  Complete submission text file 0001571049-16-013830.txt   3653304
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50626 | Film No.: 161567317
SIC: 2834 Pharmaceutical Preparations